Intellectual Property Updates

Intellectual Property Updates

NaNots are a new class of medicine: injectable nanoparticles that clear specific pathogenic molecules from blood, such as tumor-generated immune inhibitors.

We invented this technology and have received three patents to date; our most recent is very broad, covering virtually our entire therapeutic domain.

UPDATE: We were just informed that our 4th patent will be granted soon, for “programmable soluble target extractors” – the next generation of our platform.

Patents

Patent #3: US10420817 – covers any type of NaNot targeting any soluble cell surface protein

Patent #2: US9907831 – covers NaNots comprising a porous particle – ANY target

Patent #1: US9623081 – covers ANY TYPE of NaNot targeting ANY soluble receptor on cancer cell

Trademarks

Trademarks granted in Israel

Trademarks granted in Taiwan

Trademarks granted in South Korea

Trademarks granted in Mexico

Trademarks granted in Moldova

Trademarks granted in Australia

Trademarks granted in Japan

Trademarks granted in Turkey

Trademarks granted in Singapore

Trademarks granted in India

Trademarks granted in Russian Federation

EU Trademarks granted (Austria, Belgium, Denmark, Finland, France, Germany, Great Britain, Greece, Ireland, Italy, Luxembourg, the Netherlands, Portugal, Spain and Sweden.)

Trademarks granted in U.S. for “NaNot(s)” & “NaNotics” in Class 5 (Pharmaceuticals) & 10 (Medical apparatus)